AGPT registrars can commence applying to practices for the 2025.2 placement round through the Training Management System (TMS) from Monday, 28 April. Due to this, we are anticipating higher-than-usual traffic to our TMS. Although this may result in slower load times, we will actively be monitoring TMS performance and making necessary changes to remediate any issues. We apologise for any inconvenience this may cause and appreciate your patience and understanding.
Guideline for the management of knee and hip osteoarthritis
Recommendations
Last revised: 01 Jul 2018
We suggest not offering glucosamine for people with knee and/or hip osteoarthritis (OA).
Conditional against recommendation
Very low (knee) Low (hip)
We suggest not offering chondroitin for people with knee and/or hip OA.
Very low
We suggest not offering glucosamine and chondroitin in compound form for people with knee and/or hip OA.
We suggest not offering vitamin D for people with knee and/or hip OA.
Low (knee) Very low (hip
We suggest not offering omega-3 fatty acids for people with knee and/or hip OA.
We are unable to recommend either for or against the use of collagen for people with knee and/or hip OA.
Conditional (neutral) recommendation
Low (knee) Very low (hip)
We are unable to recommend either for or against the use of MSM for people with knee and/or hip OA.
We suggest not offering diacerein for people with knee and/or hip OA.
Did you know you can now log your CPD with a click of a button?
Administrative-report.pdf (PDF 2.76 MB)
Algorithm-Holistic-assessment-diagnosis-and-management-of-knee-and-hip-osteoarthritis.pdf (PDF 0.05 MB)
Guideline-for-the-management-of-knee-and-hip-osteoarthritis-2nd-ed-Appendix-1.pdf (PDF 0.04 MB)
Guideline-for-the-management-of-knee-and-hip-osteoarthritis-2nd-ed-Appendix-2.pdf (PDF 0.05 MB)
Implementation-plan.pdf (PDF 1.79 MB)
Public-consultation-summary.pdf (PDF 0.29 MB)
Technical-document.pdf (PDF 5.79 MB)
Advertising